Evidence map›Paper›PMID 23914132›Full record

ArticleMolecular vision2013

The retina rapidly incorporates ingested C20-D₃-vitamin A in a swine model.

Doina M Mihai, Hongfeng Jiang, William S Blaner, Alexander Romanov, Ilyas Washington

3 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Molecular vision, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02402660 phase2enrolling by invitationnot on this mapstarted 2015, after this paper: background citation

A Phase 2 Multicenter, Double-Masked, Randomized, Placebo-Controlled Study to Investigate the Long Term Safety, Tolerability, Pharmacokinetics and Effects of ALK-001 on the Progression of Stargardt Disease

TypeinterventionalSponsorAlkeus Pharmaceuticals, Inc.Ran2015 to 2026Enrolled160ConditionsStargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy, Autosomal Recessive Stargardt Disease 1 (ABCA4-related)ArmsALK-001, Placebo
NCT03845582 phase2 / phase3completednot on this mapstarted 2019, after this paper: background citation

A Phase 2/3 Multicenter, Randomized, Double-masked, Parallel-group, Placebo-controlled Study to Investigate the Safety, Pharmacokinetics, Tolerability, and Efficacy of ALK-001 in Geographic Atrophy Secondary to Age-related Macular Degeneration

TypeinterventionalSponsorAlkeus Pharmaceuticals, Inc.Ran2019 to 2024Enrolled200ConditionsGeographic Atrophy, Age Related Macular Degeneration, AMD, Atrophy, GeographicArmsALK-001 oral capsule, Placebo oral capsule
NCT04239625 phase2active not recruitingnot on this mapstarted 2019, after this paper: background citation

A Phase 2 Multicenter, Double-Masked, Randomized, Placebo-Controlled Study to Investigate the Long Term Safety, Tolerability, Pharmacokinetics and Effects of ALK-001 on the Progression of Stargardt Disease

TypeinterventionalSponsorAlkeus Pharmaceuticals, Inc.Ran2019 to 2026Enrolled200ConditionsStargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy, Autosomal Recessive Stargardt Disease 1 (ABCA4-related)ArmsALK-001
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Review
  3. Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Doina M MihaiDepartment of Ophthalmology, Columbia University Medical Center New York, NY, USA.
Hongfeng Jiang
William S Blaner
Alexander Romanov
Ilyas Washington
Columbia University Irving Medical Center · US

Funding

Postprandial Vitamin AR01DK068437 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BLANER, WILLIAM S · 2004 to 2023
$7.0M
The role and mechanisms of lipofuscin formation in macular degenerationR01EY021207 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WASHINGTON, ILYAS · 2011 to 2015
$1.9M
Alcohol Consumption and Brown Adipose TissueR21AA021336 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BLANER, WILLIAM S · 2013 to 2014
$414k
NEI NIH HHS 1R01EY021207NEI NIH HHS R01 EY021207NIAAA NIH HHS R21 AA021336NIDDK NIH HHS 5R01DK068437NIDDK NIH HHS R01 DK068437
6 · The paper itself

Abstract

purposeTo determine how the retina uses vitamin A for vision, we studied the flux of oral vitamin A into and out of the swine retina.

methodsWe administered labeled vitamin A to swine daily for 30 days and measured the percent of the labeled vitamin A to native unlabeled vitamin A in the retinal epithelium, neuroretina, plasma, liver, lung, and kidney.

resultsWe show that during normal vitamin A homeostasis, the retina rapidly assimilates newly ingested dietary vitamin A, which replaces native vitamin A. Retinal vitamin A is turned over faster than previously thought. Provitamin A carotenoids do not significantly contribute to retinal vitamin A pools when consuming diets adequate in vitamin A.

conclusionsFast vitamin A turnover in the retina has direct implications for emerging therapies to prevent major forms of blindness based on controlling the concentrations of retinal vitamin A.

Indexed as

AbsorptionAnimalsDeuteriumMaleModels, AnimalModels, BiologicalRetinaSus scrofaVitamin ADeuteriumVitamin A

Identifiers

PMID23914132
PMCPMC3731456
OpenAlexW2142569525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.